The role of serum potassium (K+) in modulation of serum We examined NGF and EGF concentrations i n svnaotosomal fracaldosterone concentration (Aldol during development was studied r ----. , t i o n s from mouse cerebral c o r t e x d u r i n a weanin;. Pooled c o r t e x in chronicallv-catheterized fetal (134-144 days gestation) and t i s s u e s were homogenized i n i c e -c o l d 0:32 M sucrose w i t h a glasst e f l o n homogenizer. The synaptosome enriched f r a c t i o n was then prepared by d i f f e r e n t i a l c e n t r i f u g a t i o n f o l l o w e d by a d i s c o n t i n uous sucrose d e n s i t y gradient. The p u r i t y o f the p r e p a r a t i o n was confirmed by e l e c t r o n microscopy. Synaptosomal p e l l e t s were homogenized i n phosphate b u f f e r e d s a l i n e pH 7.4 and c e n t r i f u g e d t o o b t a i n 115,000 xg supernatant r e f e r r e d t o as "synaptosomal ext r a c t (SE)". BNGF and EGF concentrations were q u a n t i f i e d by respective radioimmunoassay (RIA). The mean ( + SEM) NGF and EGF concentration i n whole b r a i n (B), cerebral c o r t e x (C) and SE were as f o l l o w s :
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Growth f a c t o r s B C SE NGF (pg/mg p r o t e i n ) 6 1 2 59f2 279t13 t EGF (pg/mg p r o t e i n ) 101f25 24+6 713+130 1 t p <0.01 vs B and C. I n t r a v e n t r i c u l a r i n j e c t i o n s o f NGF and EGF 15 minutes p r i o r t o s a c r i f i c e d i d n o t s i g n i f i c a n t l y a l t e r e i t h e r NGF o r EGF concent r a t i o n s i n SE. Summary and conclusion: a ) NGF and EGF are prese n t i n cerebral c o r t i c a l synaptosomal f r a c t i o n s i n high concent r a t i o n s , b ) t h e i r presence and d i f f e r e n t i a l d i s We have grown neonatal mouse~astrocytes ( 2 days o l d ) i n c e l l c u l t u r e f o r n i n e days followed by mechanical removal o f the contaminating oligodendrocytes. Astrocytes are continued i n c u lt u r e i n serum-free medium f o r an a d d i t i o n a l 5 days. Assays f o r both glutamine synthetase and g l i a l f i b r i l l a r y a c i d i c p r o t e i n revealed the c u l t u r e s t o contain predominantly astrocytes. C e l l p e l l e t l y s a t e s and the g l i a l conditioned medium (GCM) from these c u l t u r e s were assayed f o r BNGF synthesis and s e c r e t i o n by r a d i oimmunoassay (RIA) u s i n g BNGF p u r i f i e d from male mouse submaxill a r y gland as standard. B i o s y n t h e t i c l a b e l i n g w i t h S35-cystine l a b e l l e d a t 24 hour i n t e r v a l s f o r 120 hours demonstrated c e l l ul a r synthesis o f NGF between 72 and 96 hours w i t h s e c r e t i o n o f l a b e l l e d NGF i n t o the GCM between 96 and 120 hours. Immunoprec i p i t a t e s from c e l l homogenate supernatants and GCM on polyacrylamide gel e l e c t r o p h o r e s i s (PAGE) showed bands i n t h e same mol e c u l a r weight range as p u r i f i e d BNGF. P a r t i a l p u r i f i c a t i o n o f t h e NGF-like m a t e r i a l i n t h e GCM w i t h Sephadex 6-100 gel f i l t r at i o n showed b o t h immunoreactivity and b i o a c t i v i t y ; b i o a c t i v i t y was blocked by anti-NGF antiserum. Results and conclusions: 1 ) An NGF-like f a c t o r (NGF-LF) i s synthesized and secreted by neon a t a l mouse a s t r o c y t e s i n c u l t u r e , 2) NGF-LF i s s i m i l a r , i f n o t i d e n t i c a l t o BNGF synthesized i n t h e mouse submaxillary gland, 3) NGF-LF i s produced l o c a l l y i n normal b r a i n t i s s u e , 4) NGF-LF may be important i n t h e developing CNS. The role of endogenous angiotensin-I1 (A-11) production in modulation of potassium (K+) induced increase in serum aldosterone concentration (Aldo) was studied in chronically-catheterized newborn lambs 10-14 days of age. Captopril (5 uglkglmin) was given to one group of lambs (Exp) to block the conversion of angiotensin-I (A-I) to A-11, whereas the control group (C) received only 5% dextrose in water (0.1 mllmin). All lambs received dexamethasone phosphate (0.1 mglkgldose) 12 hours and 2 hours prior to potassium infusion (KC1) to suppress adrenocorticotropin (ACTH) secretion. Data are expressed as mean t SD. Blockade of A-I1 formation by captopril was documented by 1) at least 90% inhibition of vasopressor response (from 25+8 mmHg pre-to 2f2 mmHg post-captopril) to a bolus of A-I (1 uglkg) without altering vasopressor response (26+8 mmHg) to A-I1 (0.5 uglkg); 2) decrease in baseline serum A-I1 (from 68.1t41.2 to 46.2t18.5 pglml); and 3) increase in baseline plasma renin activity (from 13.7f4.4 to 1572138 nglmllhr). KC1 (1.80f0.09 mEq1kg) in C increased serum K+ (from 3.8t0.1 to 5.5f0.4 mEq/L, p<0.001) and Aldo (from 22.6f11.6 to 97.3t46.6 pglml, p<0.001). KC1 (1.77f0.03 mEq/kg) in Exp increased serum K+ (from 3.9k0.4 to 5.7t0.6 mEq/L, p<0.001) in a similar fashion to C, but the increment in Aldo (from 22.7f19.3 to 55.2t61.6 pglml, p<0.05) was suppressed relative to C. These data suggest that endogenous A-I1 is a modulater of K+-induced aldosterone secretion in ACTH suppressed newborn lambs. newborn (10-1; days of age) lambs. ' Dexamethasone phosphate was given to fetuses (0.1 mglkgldose) and ewes (5 mg) or newborn lambs (0.1 mglkgldose) at 12 hours and 2 hours prior to potassium infusion (KCL) to suppress adrenocorticotropin (ACTH) secretion. Data are expressed as mean t SD. KC1 (1.2t0.4 mEq/kg) in fetuses increased K+ from 4.0t0.5 to 5.4t0.6 mEq/L (p<0.001) and was associated with a small increase in Aldo (from 13.5t9.7 to 27.9t13.7 pglml, p<0.05). Plasma renin activity (PRA) and angiotensin-I1 concentration (A-11) did not change significantly (p>0.05). Maternal K+ and Aldo also did not change significantly. Similar KC1 infusion (1.8t0.1 mEq/kg) in newborns increased K+ in similar fashion (from 3.8f0.1 to 5.5t0.4 mEq/L, p<0.001) hut induced a greater increase in Aldo (from 22.6f11.8 to 97.3246.6 pglml, p<0.01). PRA and A-I1 did not change significantly. If fetuses were given higher dosages of KC1 (3.8'0.3 mEq/kg) to increase K+ further (up to 8.2t1.3 mEqIL), Aldo increased proportionately (up to 101t33 pg/ml). Newborns given high dose KC1 (4.3t0.3 mEq/kg) increased K+ (to 10.3t2.6 mEq/L) with only slight increment in Aldo (to 125.0f87.8 nglml) suggesting near-maximal stimulation. These results suggest that after ACTH suppression, KC1 induces increase in Aldo in both fetuses and newborns, but the fetal adrenal is less sensitive to such stimulation. In early extrauterine life the heart undergoes rapid anatomic development. The underlying biochemical events responsible for this change are poorly understood. We investigated the mechanism of myocardial growth in fetal and neonatal animals. Piglet hearts from 0.9 gestation(0.9G), one day(1 DPP), 5 day (5 DPP) and 10 day(l0 DPP) old animals were divided into left ventricular free wall(LVFW), right ventricular free wall(RVFW) and intraventricular septum(1VS). Between 0.9G and 10 DPP total heart weight increased from 3.63 * 0.23 to 13.63 f 0.47g. During this period, LVFW weight increased 5-fold (1.34 f 0.11: 6.70 f .18g) and IVS increased almost 4-fold (0.93 t 0.06: 3.71 t 0.16g). RVFW demonstrated an approximate 2.5-fold increment in growth (1.31 f 0.08 3.22 t .17g). Total protein content parallels total RNA content of each myocardial structure at every age studied. Nuclearhyperplasia was greater in the LVFW and IVS than in the RV (DNAlevels Experiments to reduce umbilical blood flow have demonstrated varying PO2 results in the umbilical vein ranging from no significant change to increases in umbilical vein P02. A clarification of these observations is important in order to understand the respiratory function of the placenta. Eleven paired experiments in 5 sheep were performed with an occluder around the fetal abdominal aorta (Group I). Eight paired experiments in 4 sheep were performed with an occluder around one umbilical artery (Group 11). PO2 and O2 content were measured across the umbilical and uterine circulations. Umbilical and uterine blood flow were determined by application of the Fick Principle. Umbilical blood flow was reduced up to 30% of normal. Fetal 02 consumption decreased up to 60% of normal. In Group I, when fetal 02 consumption was unchanged by occlusion, PO2 in the umbilical vein remained constant. When fetal 02 consumption decreased, umbilical vein PO2 increased. In Group 11, there was a consistent decrease in umbilical vein P02.(AP02 = -5.4 -f 1.2 torr). These data demonstrate that the magnrtude and direction of changes in umbilical venous PO2 depends upon several factors, i.e., whether the reduction in umbilical blood flow occurs evenly (Group I) or unevenly (Group 11) and whether fetal O2 consumption remains constant or decreases.
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